Lee Health Approves Expansion of HeraMED Maternity Program
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Lee Health has approved the full-scale expansion of HeraMED's maternity program following a successful pilot, marking a significant step in the company's US commercialization strategy. The deployment will establish a recurring SaaS model within a major US health system, enhancing HeraMED's revenue as it scales up operations. The initial phase will onboard the next group of pregnant women, integrating HeraMED's technology with Lee Health's existing systems. This expansion validates HeraMED's market entry strategy and aims to improve maternal-fetal care outcomes through innovative technology.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from HeraMED
- Trading Halt
- Notification regarding unquoted securities - HMD
- Appendix 4D and Half Year Report
- Resignation and Appointment of Joint Company Secretary
- Quarterly Activities & Cashflow Report
Later from HeraMED
All HeraMED news releasesFollow HeraMED into a list and get an email when it puts out news.
Follow HeraMED